TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 59 filers reported holding TANGO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,571,385 | +410.5% | 2,892,663 | +50.5% | 3.64% | +454.3% |
| Q2 2023 | $6,380,343 | +83951.4% | 1,921,790 | 0.0% | 0.66% | -30.8% |
| Q1 2023 | $7,591 | -45.5% | 1,921,790 | 0.0% | 0.95% | -39.0% |
| Q4 2022 | $13,933 | -99.8% | 1,921,790 | 0.0% | 1.56% | +87.6% |
| Q3 2022 | $6,957,000 | -20.1% | 1,921,790 | 0.0% | 0.83% | -18.7% |
| Q2 2022 | $8,706,000 | -40.2% | 1,921,790 | 0.0% | 1.02% | -27.8% |
| Q1 2022 | $14,567,000 | -30.7% | 1,921,790 | 0.0% | 1.42% | -15.1% |
| Q4 2021 | $21,024,000 | -15.4% | 1,921,790 | 0.0% | 1.67% | +8.2% |
| Q3 2021 | $24,849,000 | – | 1,921,790 | – | 1.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,363,975 | $218,038,359 | 82.15% |
| Nextech Invest Ltd. | 5,533,980 | $62,312,615 | 18.88% |
| Boxer Capital, LLC | 7,123,642 | $80,212,209 | 4.27% |
| Bain Capital Life Sciences Investors, LLC | 2,892,663 | $32,571,385 | 3.64% |
| EcoR1 Capital, LLC | 8,721,636 | $98,205,621 | 3.31% |
| Samsara BioCapital, LLC | 630,000 | $7,093,800 | 2.17% |
| Soleus Capital Management, L.P. | 1,929,019 | $21,720,754 | 2.00% |
| Casdin Capital, LLC | 1,307,349 | $14,720,750 | 1.63% |
| Southpoint Capital Advisors LP | 5,276,699 | $59,415,631 | 1.33% |
| Affinity Asset Advisors, LLC | 350,000 | $3,941,000 | 1.11% |